The cancer immunotherapy environment may confound the utility of anti-TIF-1γ in differentiating between paraneoplastic and treatment-related dermatomyositis. Report of a case and review of the literature

The cancer immunotherapy environment may confound the utility of anti-TIF-1γ in differentiating between paraneoplastic and treatment-related dermatomyositis. Report of a case and review of the literature

With the advent of immunotherapy and with the expanding spectrum of malignancies treated with immunomodulatory agents, a new kind of adverse events has come under the spotlight. Clinicians have to be aware of immune-related adverse events and their clinical manifestations. Immunotherapy has been str...

Full description

Bibliographic Details
Main Authors: George Zarkavelis, Davide Mauri, Fotini Karassa, Kampletsas Eleftherios, George Pentheroudakis, Alexandra Pappadaki, Leonidas Mavroeidis, Panagiotis Ntellas, Stefania Gkoura, Ioanna Gazouli
Format: Article
Language:English
Published: Termedia Publishing House 2020-03-01
Series:Contemporary Oncology
Subjects:
urothelial cancer
dermatomyositis
immunotherapy
ipilimumab
nivolumab
anti-tif-1γ
paraneoplastic
autoimmune
Online Access:https://www.termedia.pl/The-cancer-immunotherapy-environment-may-confound-the-utility-of-anti-TIF-1-in-differentiating-between-paraneoplastic-and-treatment-related-dermatomyositis-Report-of-a-case-and-review-of-the-literatur,3,40484,1,1.html

Internet

https://www.termedia.pl/The-cancer-immunotherapy-environment-may-confound-the-utility-of-anti-TIF-1-in-differentiating-between-paraneoplastic-and-treatment-related-dermatomyositis-Report-of-a-case-and-review-of-the-literatur,3,40484,1,1.html

Similar Items